- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Total 1299 results
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)Terminated
-
Shenzhen TargetRx, Inc.M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
University of Maryland, BaltimoreUniversity of Maryland Greenebaum Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaTerminated
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCompleted
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Ariad PharmaceuticalsCompletedChronic Myelogenous Leukemia | Hematologic MalignanciesUnited States
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaJapan
-
III. Medizinische Klinik MannheimUnknownLeukemiaSwitzerland, Germany, Spain, Poland, Czech Republic
-
Fred Hutchinson Cancer CenterWithdrawnRecurrent Hodgkin Lymphoma | Myelofibrosis | Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Chronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Hematopoietic and Lymphoid System Neoplasm | Recurrent... and other conditionsUnited States
-
Shenzhen TargetRx, Inc.Peking University People's HospitalRecruitingChronic Myelogenous LeukemiaChina
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaUnited States, United Kingdom, Hungary, Japan, Saudi Arabia, Australia, Germany, Canada, France, Netherlands, Spain, Lebanon, Turkey, Korea, Republic of, Argentina, Brazil, Bulgaria, Czechia, Israel, Italy, Mexico, Romania, Russian... and more
-
M.D. Anderson Cancer CenterRecruitingChronic Myelogenous LeukemiaUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI); Beth Israel Deaconess Medical CenterCompleted
-
ShireCompleted
-
M.D. Anderson Cancer CenterCompletedMyelogenous Leukemia, ChronicUnited States
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompleted
-
Medical Research CouncilUnknownLeukemiaUnited Kingdom
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)Unknown
-
German CML Study GroupUnknown
-
Barbara Ann Karmanos Cancer InstituteNational Cancer Institute (NCI)Completed
-
NovartisNational Cancer Institute (NCI)Completed
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Bristol-Myers SquibbCompletedChronic Myelogenous LeukemiaNetherlands, United States, Italy, Argentina, Brazil, Canada, Germany, Peru, Singapore, Taiwan, United Kingdom, France, Korea, Republic of, Philippines, Sweden, Thailand, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzer...
-
University of California, San FranciscoAmerican Society of HematologyCompletedChronic Myeloid Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Myeloproliferative NeoplasmUnited States
-
University Hospital, AngersCompletedSolid Tumor | Endothelial Dysfunction | Tumor Angiogenesis | CML (Chronic Myelogenous Leukemia)France
-
American University of Beirut Medical CenterRecruitingChronic Myelogenous LeukemiaLebanon
-
University of Southern CaliforniaNational Cancer Institute (NCI)WithdrawnGastrointestinal Stromal Tumor | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | PremenopausalUnited States
-
NovartisCompletedLeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedAccelerated Phase Chronic Myelogenous Leukemia | Adult Acute Lymphoblastic Leukemia in Remission | Childhood Acute Lymphoblastic Leukemia in Remission | Childhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Recurrent Adult Acute Lymphoblastic Leukemia | Recurrent... and other conditionsUnited States
-
Novartis PharmaceuticalsActive, not recruitingChronic Myelogenous LeukemiaSpain, United Kingdom, Germany, Canada, Austria, France, Korea, Republic of, Greece, Singapore, Italy, Argentina, Poland, Vietnam, Malaysia, Oman, Brazil
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Terminated
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)TerminatedLeukemiaUnited States
-
NovartisCompleted
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsTerminatedMyelogenous LeukemiaUnited States, Germany, Belgium, Italy, Spain, Korea, Republic of, Brazil, Japan, Australia, Czech Republic
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Completed
-
Centre Hospitalier Universitaire de NiceUnknownLeukemia, Myelogenous, Chronic, BCR-ABL Positive
-
Asan Medical CenterCompletedLeukemia, Myelogenous, Chronic, BCR-ABL PositiveKorea, Republic of, Canada
-
Bristol-Myers SquibbCompletedMyeloid Leukemia, Chronic, Chronic-PhaseUnited States, Australia, France, Germany, Italy, Korea, Republic of, Sweden, Taiwan, Spain, Austria, Denmark, Belgium, Canada, Ireland, Switzerland, Netherlands, Peru, United Kingdom, South Africa, Argentina, Philippines, Singapore, Russian Federation and more
-
Baylor Research InstituteCompletedMyelodysplastic Syndromes | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
Siriraj HospitalRecruiting
-
Novartis PharmaceuticalsCompletedPhiladelphia Chromosome Positive | Chronic Myelogenous Leukemia in Chronic PhaseJapan
-
Sarit AssoulineNovartisRecruitingChronic Myeloid Leukemia | Chronic Myeloid Leukemia in Remission | Chronic Myeloid Leukemia, BCR/ABL-PositiveCanada